Compare VENUS REMEDIES with FDC LTD. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

VENUS REMEDIES vs FDC LTD. - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    VENUS REMEDIES FDC LTD. VENUS REMEDIES/
FDC LTD.
 
P/E (TTM) x -1.5 16.2 - View Chart
P/BV x 0.1 2.2 4.9% View Chart
Dividend Yield % 0.0 0.0 -  

Financials

 VENUS REMEDIES   FDC LTD.
EQUITY SHARE DATA
    VENUS REMEDIES
Mar-18
FDC LTD.
Mar-18
VENUS REMEDIES/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs126319 39.5%   
Low Rs61164 37.3%   
Sales per share (Unadj.) Rs301.861.6 489.6%  
Earnings per share (Unadj.) Rs-24.99.9 -250.0%  
Cash flow per share (Unadj.) Rs2.512.0 21.3%  
Dividends per share (Unadj.) Rs00-  
Dividend yield (eoy) %00-  
Book value per share (Unadj.) Rs293.373.2 400.8%  
Shares outstanding (eoy) m12.34174.40 7.1%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x0.33.9 7.9%   
Avg P/E ratio x-3.824.3 -15.5%  
P/CF ratio (eoy) x36.720.2 182.0%  
Price / Book Value ratio x0.33.3 9.7%  
Dividend payout %00-   
Avg Mkt Cap Rs m1,15442,118 2.7%   
No. of employees `0000.95.5 16.7%   
Total wages/salary Rs m3932,167 18.1%   
Avg. sales/employee Rs Th4,026.11,943.7 207.1%   
Avg. wages/employee Rs Th425.0391.7 108.5%   
Avg. net profit/employee Rs Th-331.8313.7 -105.8%   
INCOME DATA
Net Sales Rs m3,72410,751 34.6%  
Other income Rs m23510 4.4%   
Total revenues Rs m3,74711,260 33.3%   
Gross profit Rs m3952,267 17.4%  
Depreciation Rs m338351 96.3%   
Interest Rs m35414 2,530.7%   
Profit before tax Rs m-2752,411 -11.4%   
Minority Interest Rs m0-5 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m32671 4.7%   
Profit after tax Rs m-3071,735 -17.7%  
Gross profit margin %10.621.1 50.3%  
Effective tax rate %-11.527.8 -41.2%   
Net profit margin %-8.216.1 -51.1%  
BALANCE SHEET DATA
Current assets Rs m2,6387,213 36.6%   
Current liabilities Rs m2,3052,104 109.6%   
Net working cap to sales %8.947.5 18.8%  
Current ratio x1.13.4 33.4%  
Inventory Days Days13554 248.5%  
Debtors Days Days4628 167.1%  
Net fixed assets Rs m4,8716,865 71.0%   
Share capital Rs m123175 70.4%   
"Free" reserves Rs m3,49612,586 27.8%   
Net worth Rs m3,61912,761 28.4%   
Long term debt Rs m1,3746 22,906.7%   
Total assets Rs m7,50915,041 49.9%  
Interest coverage x0.2173.2 0.1%   
Debt to equity ratio x0.40 80,769.9%  
Sales to assets ratio x0.50.7 69.4%   
Return on assets %0.611.6 5.4%  
Return on equity %-8.513.6 -62.4%  
Return on capital %1.619.0 8.3%  
Exports to sales %012.3 0.0%   
Imports to sales %13.90-   
Exports (fob) Rs mNA1,327 0.0%   
Imports (cif) Rs m517NA-   
Fx inflow Rs m01,889 0.0%   
Fx outflow Rs m5170-   
Net fx Rs m-5171,889 -27.3%   
CASH FLOW
From Operations Rs m5141,498 34.3%  
From Investments Rs m-123201 -61.2%  
From Financial Activity Rs m-387-1,694 22.8%  
Net Cashflow Rs m410 40.8%  

Share Holding

Indian Promoters % 32.9 68.9 47.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.2 4.7 3.8%  
FIIs % 0.6 7.5 7.7%  
ADR/GDR % 0.0 0.0 -  
Free float % 66.4 19.0 349.5%  
Shareholders   20,121 23,730 84.8%  
Pledged promoter(s) holding % 36.4 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare VENUS REMEDIES With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  ELDER PHARMA  NOVARTIS  DR. DATSONS LABS  

Compare VENUS REMEDIES With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Indian Stock Markets Remain in Green This Week: Is the Rebound Here?(Podcast)

After a long period of underperformance, stock markets traded in green territory throughout the week. So, is this is a trend reversal and is the bottom forming in the market?

Related Views on News

FDC LTD. Announces Quarterly Results (1QFY20); Net Profit Up 2.4% (Quarterly Result Update)

Aug 6, 2019 | Updated on Aug 6, 2019

For the quarter ended June 2019, FDC LTD. has posted a net profit of Rs 523 m (up 2.4% YoY). Sales on the other hand came in at Rs 3 bn (up 17.9% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

VENUS REMEDIES Announces Quarterly Results (4QFY19); Net Profit Down 11.1% (Quarterly Result Update)

Jun 12, 2019 | Updated on Jun 12, 2019

For the quarter ended March 2019, VENUS REMEDIES has posted a net profit of Rs 104 m (down 11.1% YoY). Sales on the other hand came in at Rs 864 m (down 7.3% YoY). Read on for a complete analysis of VENUS REMEDIES's quarterly results.

FDC LTD. Announces Quarterly Results (4QFY19); Net Profit Up 6.8% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, FDC LTD. has posted a net profit of Rs 337 m (up 6.8% YoY). Sales on the other hand came in at Rs 3 bn (down 0.6% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

FDC LTD. 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of FDC LTD. for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of FDC LTD.. Also includes updates on the valuation of FDC LTD..

VENUS REMEDIES Announces Quarterly Results (3QFY19); Net Profit Down 2301.8% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, VENUS REMEDIES has posted a net profit of Rs 119 m (down 2301.8% YoY). Sales on the other hand came in at Rs 691 m (down 25.8% YoY). Read on for a complete analysis of VENUS REMEDIES's quarterly results.

More Views on News

Most Popular

My 3 Best Small-cap Stocks to Get Rich in this Market Rebound(Profit Hunter)

Oct 14, 2019

This is once in a decade opportunity to make a killing from smallcap rebound.

Two Stocks to Buy in the Great Indian Festival(Profit Hunter)

Oct 11, 2019

Discounts are not just limited to E-tailers. You can buy stocks at 50% off too. Here are two stocks to buy now.

Buy these 3 Stocks for Rebound Riches

Oct 18, 2019

Equitymaster's smallcap guru and editor of Hidden Treasure, Richa Agarwal, talks to us about the rebound in the stock market, and the best stocks to profit from it. Listen in...

The One Stock I Like in this Market(The 5 Minute Wrapup)

Oct 10, 2019

There are rare periods in markets when you get good quality stocks at attractive valuations. Is this one such period?

5 Smart Money Stocks to Profit from the Market Rebound(The 5 Minute Wrapup)

Oct 11, 2019

Now is the time to put money in these 5 stocks to take advantage of the recovery in the economy and the markets.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

VENUS REMEDIES SHARE PRICE


Oct 18, 2019 (Close)

TRACK VENUS REMEDIES

  • Track your investment in VENUS REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON VENUS REMEDIES

VENUS REMEDIES 5-YR ANALYSIS

COMPARE VENUS REMEDIES WITH

MARKET STATS